Experimental gene therapy targets rare dementia in 35-Patient trial
NCT ID NCT04408625
First seen Jan 09, 2026 · Last updated May 17, 2026 · Updated 18 times
Summary
This early-stage study tests a gene therapy called LY3884963 in 35 adults with frontotemporal dementia caused by a GRN gene mutation. The treatment is given as a single injection into the fluid around the brain and aims to raise levels of a protective protein called progranulin. The main goals are to check safety and see if the therapy can slow the disease over 5 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRONTOTEMPORAL DEMENTIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AP-HM Hôpital de La Timone
Saint-Pierre, Marseille, 13386, France
-
Centre Mémoire de Ressources
Lille, 59000, France
-
Hospital Clinic de Barcelona, Villaroel 170 Servicio de Neurología
Barcelona, 08036, Spain
-
Hospital Universitario de Donostia, Servicio De Neurologia, Consultas Externas Neurologia, San Sebastian, Guipúzcoa
Donostia / San Sebastian, 20014, Spain
-
Hospital of the University of Pennsylvania, 3 West Gates Building, 3400 Spruce Street
Philadelphia, Pennsylvania, 19104, United States
-
Lahey Hospital & Medical Center, 41 Burlington Mall Road
Burlington, Massachusetts, 01805, United States
-
Le Ber, Institut du Cerveau et de la Moelle Epinière
Paris, 75013, France
-
PPD Phase 1 Clinic, 100 West Gore Street, Suite 202
Orlando, Florida, 32806, United States
-
Royal Prince Alfred Hospital, Brain & Mind Research Institute, 94 Mallet Street
Camperdown, New South Wales, 2050, Australia
-
UZ Leuven, Neurologie Herestraat 49
Leuven, 3000, Belgium
-
University College London,Queen Square, Dementia Research Building, London,
London, WC1N 3BG, United Kingdom
-
k2 Medical Research-Maitland
Maitland, Florida, 32751-5669, United States
Conditions
Explore the condition pages connected to this study.